Spectrum Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
SPPI Spectrum Pharmaceuticals Inc
KRTX Karuna Therapeutics Inc
SNSE Sensei Biotherapeutics Inc
ALGS Aligos Therapeutics Inc
SRRA Sierra Oncology Inc
ATOS Atossa Therapeutics Inc
OSMT Osmotica Pharmaceuticals PLC
SAND Sandstorm Gold Ltd
GRVI Grove Inc
STON Stonemor Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. Its pipeline products include ROLONTIS, Poziotinib and Anti-CD20-IFNa. ROLONTIS (eflapegrastim injection), is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib, is a pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. Anti-CD20-IFNa, is an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for treating relapsed or refractory non-Hodgkin's lymphoma (NHL) patients.

Price
Delayed
$1.54
Day's Change
0.01 (0.65%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.55
Day's Low
1.49
Volume
(Light)

Today's volume of 790,328 shares is on pace to be much lighter than SPPI's 10-day average volume of 8,054,758 shares.

790,328
  • Prev Close
    1.53
  • Today's Open
    1.53
  • Day's Range
    1.49-1.55
  • Avg Vol (10-day)
    8.1M
  • Last (time)
    10:57a ET 12/08/21
  • Last (size)
    2.0K
  • 52-Wk Range
    1.30 - 5.24
    LowHigh
  • (12/15/20 - 12/06/21)
    18.46%
  • 65.8%
  • Market Cap
    250.0M
  • Shares Outstanding
    164.0M
  • -1.13
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.9
  • 63.88
  • (% of float 11/15/21)
    10.03

Latest News

December 06, 2021
7:00 am ET
BusinessWire
December 01, 2021
4:00 pm ET
BusinessWire
November 30, 2021
7:00 am ET
BusinessWire
November 11, 2021
7:00 am ET
BusinessWire
November 10, 2021
4:00 pm ET
BusinessWire
November 03, 2021
7:00 am ET
BusinessWire
6:02 am ET
BusinessWire
November 01, 2021
4:15 pm ET
Newsfile
2:37 pm ET
Newsfile
2:11 pm ET
Globe Newswire
1:48 pm ET
Newsfile
11:31 am ET
Accesswire
11:06 am ET
BusinessWire
10:00 am ET
Newsfile
9:14 am ET
Newsfile
9:11 am ET
Newsfile
7:46 am ET
Accesswire
October 31, 2021
10:35 am ET
Accesswire
October 30, 2021
1:18 pm ET
Globe Newswire
October 29, 2021
3:53 pm ET
Newsfile
2:23 pm ET
Globe Newswire
2:01 pm ET
Newsfile
1:56 pm ET
Accesswire
12:42 pm ET
Accesswire
11:00 am ET
BusinessWire
9:01 am ET
Accesswire
7:41 am ET
Accesswire
October 28, 2021
5:46 pm ET
Newsfile
4:15 pm ET
Newsfile
3:06 pm ET
Newsfile
1:37 pm ET
Newsfile
12:30 pm ET
Newsfile
11:02 am ET
Accesswire
8:59 am ET
Newsfile
7:31 am ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.